miércoles, 23 de enero de 2019

Orkambi Approved in Europe for Young CF Patients with F508del Mutation

Orkambi Approved in Europe for Young CF Patients with F508del Mutation

Cystic Fibrosis News Today

Orkambi Approved in Europe for Younger CF Patients with F508del Mutations

No hay comentarios:

Publicar un comentario